Pathalys Pharma Revenue and Competitors
Estimated Revenue & Valuation
- Pathalys Pharma's estimated annual revenue is currently $775k per year.
- Pathalys Pharma's estimated revenue per employee is $59,615
Employee Data
- Pathalys Pharma has 13 Employees.
- Pathalys Pharma grew their employee count by 63% last year.
Pathalys Pharma's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Co-Founder & SVP Operations | Reveal Email/Phone |
3 | Chief Medical Officer and SrVP Clinical Development | Reveal Email/Phone |
4 | Chief Operating Officer | Reveal Email/Phone |
5 | SVP, Technical Operations | Reveal Email/Phone |
6 | VP Finance | Reveal Email/Phone |
Pathalys Pharma Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $11.2M | 72 | -13% | N/A | N/A |
#2 | $5099.8M | 32902 | -4% | N/A | N/A |
#3 | $1.7M | 11 | 0% | N/A | N/A |
#4 | $0.6M | 4 | -56% | N/A | N/A |
#5 | N/A | 15 | 7% | N/A | N/A |
#6 | $0.9M | 11 | -39% | N/A | N/A |
#7 | $1.7M | 11 | 10% | N/A | N/A |
#8 | $0.6M | 4 | -33% | N/A | N/A |
#9 | $4.8M | 31 | -6% | N/A | N/A |
#10 | $6.4M | 41 | 3% | N/A | N/A |
What Is Pathalys Pharma?
Pathalys Pharma is a private, late-stage clinical biopharmaceutical company committed to the development of advanced therapeutics that address unmet needs in the management of late-stage chronic kidney disease (CKD). Pathalys was created in partnership with Catalys Pacific and DaVita to become a multi-asset pharmaceutical company focused on the needs of patients with end-stage renal disease.
keywords:N/AN/A
Total Funding
13
Number of Employees
$775k
Revenue (est)
63%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | N/A | 13 | 63% | N/A |
#2 | $1.4M | 13 | -28% | N/A |
#3 | $2.1M | 13 | 44% | N/A |
#4 | $2.7M | 13 | N/A | N/A |
#5 | $1.7M | 13 | 63% | N/A |